Deliver your company news, directly to investors, where they look for it.
Today more than ever, you must reach investors with relevant and concise information.
Institutional Investors
- ABN Newswire is globally accredited to the top tier of financial news via Bloomberg, Thomson Reuters, Dow Jones Factiva and more. We deliver text and video directly to institutional desktops.
- Read More
Retail Investors
- Reaching retail investors via equity websites, search engines and financial blogs is no longer out of reach with ABN Newswire's unique distribution model. Your news is easily integrated on any website.
- Read More
Social Investors
- Instant broadcasting of your news, images and video through LinkedIn, Facebook and Twitter. Reduce your time and effort posting on Social Media, we do it for you.
- Read More
Professional Audience
Companies Represented
Pages Served
Languages

News Distribution
rapid
Video Production
+live webcasting
Investment Shows
investorium.tv
CEO Interviews
+corporate video
Hosted AGMs
+webcast
IR Websites
+multiple languages
Social Media
+postingWhy Choose Us
With years of cutting edge software development, ABN Newswire has integrated with every major news provider and social media in multiple languages...
ABN Newswire monitors your newsflow and knows instantly when you make a company announcement. Our alert system tells you we are already working on distributing your news...
Our reporting tells you how many are reading your news, referrals to your website and your most read announcements by week, month and year, with interactive stock price and news reads chart data...
Recent News
- 4Apr2025
Altech Batteries Ltd (ASX:ATC) CERENERGY at Hannover International Industrial Fair
Altech Batteries Limited (ASX:ATC) (FRA:A3Y) (OTCMKTS:ALTHF) is pleased to announce that the Company showcased it's CERENERGY(R) Battery technology at the prestigious Hannover Messe 2025, the world's leading industrial trade fair.
Read More
- 3Apr2025
NEXT Life Sciences Announces Successful Plan A™ Delivery Device Clinical Trial in Australia
NEXT Life Sciences, the modern reproductive healthcare company pioneering Plan A™, a first-of-its-kind, long-lasting, and on-demand reversible male contraceptive in development, announces the successful completion of its clinical trial in Australia with a 100% success rate.
Read More